Skip to main content

Considerations for Regulating Intoxicating Hemp Products

Explore our report, published November 8, 2024, to access the full text, including a list of sources and references used.

Report
Abstract Summary
Link
Report
Cannabis Policy Impacts Public Health and Health Equity (by a committee of the National Academies of Sciences, Engineering, and Medicine and coauthored by DEPC Executive Director, Douglas Berman)
Abstract Summary

Over the past several decades, more than half of all U.S. states have legalized cannabis for adult and/or medical use, but it remains illegal at the federal level. The public health consequences of cannabis policy changes have not been comprehensively evaluated.

Therefore, the Centers for Disease Control and Prevention and the National Institutes of Health tasked the National Academies with reviewing cannabis and cannabinoid availability in the U.S., assessing regulatory frameworks for the industry with an emphasis on equity, and describing strengths and weaknesses of surveillance systems for cannabis.

The resulting report finds that there has been limited federal guidance to states regarding protecting public health, which has led to inconsistent protection across the states. The report recommends a strategy to minimize public health harms through stronger federal leadership, a robust research agenda, and more.

Report
Cliffs Without Fences and Fences Without Cliffs: Exploring the Emerging Conflicts Between Quasi-Legal Intoxicating Hemp and Regulated State-Legal Cannabis
Abstract Summary

The Agriculture Improvement Act of 2018 (the “Farm Act”) sparked the proliferation of Intoxicating Hemp Derivatives throughout interstate commerce. Sales of these largely unregulated consumable products have swept the nation with sales revenue that rivals the combined revenue of all state-specific, regulated marijuana industries. Proponents of these mostly untested hemp-derived products see unburdened business opportunity. Opponents object to the perceived unfairness of these unregulated products in the face of marijuana’s continued federal illegality and strict state regulations. Against that backdrop, expected amendments to the Farm Act will likely address Intoxicating Hemp Derivatives, creating a moment of uncertainty for access to psychoactive cannabinoids, whether from hemp or marijuana. In this article, Benton Bodamer, DEPC adjunct professor of law, along with Benjamin Sobczak and Taylor MacDonald, explain the current state of affairs, discuss the possible implications of forthcoming federal policy decisions, and highlight the various interest groups lobbying for legislative action. Additionally, the authors argue that these new proposed regulations do not represent a solution to the federal government’s decades-old inability to safely and predictably allow access to the cannabis plant with reasonable and logical safeguards.